In this issue:
Overall survival with adjuvant pembrolizumab in RCC
Increasing burden of testicular seminomas in young adults
Treatment-free survival outcomes of nivolumab in advanced RCC
HPV infection and treatment outcomes
Treatment patterns and outcomes in prostate cancer
First-line dual ICI therapies vs combination therapies in RCC
A population-based validation of the IGCCCG consortium in testis cancer
Long-term outcomes of chemoradiation in bladder cancer
RCT of robot versus conventional open partial nephrectomy
Retroperitoneal lymph node dissection in clinical-stage metastatic seminoma
Please login below to download this issue (PDF)